Furthermore, the Ki-67 staining of BLCA cells treated with avasimibe was decreased obviously (Figure 2F), indicating that the tumorigenesis ability of the cells was inhibited by avasimibe. Here, MKI67 is linked to bladder transitional cell carcinoma.